MHE December 2021

The discount retailer signaled this summer that it was preparing to get into the delivery of healthcare.

For some, the premiums may not make the coverage worth it. Low payment rates often limit access to those with dental coverage through Medicaid

Prescription digital therapeutics are FDA approved and available only by prescription. Their developers are aiming to get them covered by insurers.

At the state and local levels, an increasing number of markets are dominated by one or a handful of insurers. Experts say it is part of a vicious cycle of payers responding to provider consolidation and vice versa.

Screening dipped sharply in 2020 because of the pandemic. The rebound this year is uneven and there is still hesitancy.

The COVID-19 pandemic has disrupted healthcare and many parts of the U.S. economy, but employer-based health insurance?

The Oncology Care Model (OCM) was CMS’ main attempt to usher value-based care into oncology. What will come after OCM is unclear as the future of successor, Oncology Care First, is now very much in doubt.

Drugs in development and newly approved drugs for non-small cell lung cancer are based on research that has identified driver mutations leading to runaway cell growth and division that characterize cancer.